1. Home
  2. HAE vs PTY Comparison

HAE vs PTY Comparison

Compare HAE & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$60.24

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

HOLD

Current Price

$12.10

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAE
PTY
Founded
1971
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
1996
2002

Fundamental Metrics

Financial Performance
Metric
HAE
PTY
Price
$60.24
$12.10
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$84.13
N/A
AVG Volume (30 Days)
531.4K
1.4M
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
44.54
N/A
EPS
2.46
N/A
Revenue
$910,373,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.23
N/A
P/E Ratio
$25.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.32
$11.58
52 Week High
$87.32
$14.69

Technical Indicators

Market Signals
Indicator
HAE
PTY
Relative Strength Index (RSI) 53.79 45.56
Support Level $48.47 N/A
Resistance Level $66.86 $13.21
Average True Range (ATR) 1.87 0.15
MACD 0.70 0.04
Stochastic Oscillator 73.37 68.59

Price Performance

Historical Comparison
HAE
PTY

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

Share on Social Networks: